中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

风湿性心脏病合并持续性心房颤动患者左心房内径增大对心房肌组织 AngⅡ/Rac1/STAT3 途径表达的影响

查看全文

目的 探讨风湿性心脏病合并持续性心房颤动(房颤)患者左心房内径增大对心房肌组织纤维化程度以及血管紧张素 Ⅱ(AngⅡ)/Rac GTP 酶激活蛋白 1(Rac1)/信号转导与转录激活因子 3(STAT3)信号途径表达水平的影响。 方法 选取 2011 年 3~12 月 30 例在我院行人工瓣膜置换术的风湿性心脏病患者,其中男16 例、女 14 例,年龄 42~70(56.9±6.8)岁。将 10 例窦性心律患者为作对照组(A 组);合并持续性房颤 20 例患者为病例组,按左心房内径(LAD)分为两组,B 组 LAD 50~65 mm(n=10),C 组 LAD>65 mm (n=10)。术中建立体外循环后获取右心耳组织标本,采用 HE 及 Masson 染色,并辅以显微图像分析软件计算组织纤维化程度。酶联免疫吸附试验检测心房肌组织的AngⅡ 浓度和蛋白印迹法检测心房肌组织 Rac1、STAT3 蛋白的表达。 结果 房颤患者左心房内径与对照组比较明显增大。随着左房内径增加,HE 染色显示心肌细胞体积增大、数量减少,同时心肌细胞排列紊乱加重及细胞核大小不均一。此外 Masson 染色显示心房肌细胞周围胶原纤维沉积明显增加并分割包绕。心房肌组织中 AngⅡ 浓度、Rac1 与 STAT3 蛋白表达水平随左心房内径增大表达水平增强,并与左心房内径呈正相关。 结论 风湿性心脏病合并持续性房颤患者,心房肌组织纤维化程度以及 AngⅡ/Rac1/STAT3 信号途径表达水平随左心房内径增大明显增强。

Objective To evaluate the effect of left atrial enlargement on atrial myocardial fibrosis degree and levels of the angiotensinⅡ (AngⅡ)/Rac GTPase activating protein 1 (Rac1)/signal transducersand activators of transcription 3 (STAT3) signaling pathways expressing in patients with persistent atrial fibrillation and rheumatic heart disease (RHD). Methods From March to December 2011, 30 patients with RHD who underwent prosthetic valve replacement in our hospital were enrolled, including 16 males and 14 females, aged 42-70 (56.9±6.8) years. Twenty RHD patients with persistent atrial fibrillation as a research group and ten RHD patients with sinus rhythm as a control group (group A) underwent transthoracic echocardiography and right atrial appendage (RAA) tissue samples were obtained from these patients during mitral/aortic valve replacement operation. The research group according to left atrial diameter (LAD) was divided into two groups, ten patients in each group: a group B with LAD of 50–65 mm and a group C with LAD of LAD>65 mm. For each sample, histological examination was performed by hematoxylin-eosin and Masson’s trichrome staining. Light-microscopic pictures of atrial tissues samples were stained and tissue fibrosis degree in each group was analyzed. AngⅡ concentration was measured by enzyme linked immunosorbent assay. Rac1 and STAT3 were measured by western blotting. Results LAD was significantly greater in AF patients with RHD than in the control group. Hematoxylin-eosin staining demonstrated highly organized arrangement of atrial muscles in the control group and significant derangement in both group B and group C with reduced cell density and increased cell size. Moreover, Masson’s trichrome staining showed that atrial myocytes were surrounded by large trunks of collagen fibers in both group B and group C, but not in the group A. There was a positive correlation between atrial tissue fibrosis and LAD. AngⅡ content was positively correlated with LAD. Similarly, Rac1 and STAT3 protein levels were found considerably higher in the group C and group B than in the group A with excellent correlation to LAD. Conclusion In patients with RHD complicated with persistent atrial fibrillation, the degree of atrial fibrosis and the expression level of AngⅡ/Rac1/STAT3 signaling pathways significantly increase with the left atrialenlargement.

关键词: 心房颤动; 风湿性心脏病; 血管紧张素 Ⅱ; Rac GTP 酶激活蛋白 1; 信号转导与转录激活因子 3

Key words: Atrial fibrillation; rheumatic heart disease; angiotensinⅡ; Rac GTPase activating protein 1; signal transducers and activators of transcription 3

引用本文: 兰怀, 王辉山, 薛晓东, 尹宗涛, 祝岩, 韩劲松, 马东初, 蒲菲菲. 风湿性心脏病合并持续性心房颤动患者左心房内径增大对心房肌组织 AngⅡ/Rac1/STAT3 途径表达的影响. 中国胸心血管外科临床杂志, 2018, 25(11): 993-999. doi: 10.7507/1007-4848.201710021 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 1998, 98(10): 946-952.
2. Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol, 1996, 77(1): 96-98.
3. Cardin S, Libby E, Pelletier P, et al. Contrasting gene expression profiles in two canine models of atrial fibrillation. Circ Res, 2007, 100(3): 425-433.
4. Everett TH 4th, Li H, Mangrum JM, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation, 2000, 102(12): 1454-1460.
5. Li D, Shinagawa K, Pang L, et al. Effects of angiotensin eonveing enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation, 2001, 104(21): 2608-2614.
6. Nazir SA, Lab MJ. Mechanoelectric feedback in the atrium of the isolated guinea-pig heart. Cardiovasc Res, 1996, 32(1): 112-119.
7. Tsai CT, Lai LP, Kuo KT, et al. Angiotensin Ⅱ activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation, 2008, 117(3): 344-355.
8. Spach MS. Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. Circ Res, 2007, 101(8): 743-745.
9. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J, 2006, 27(5): 512-518.
10. Dostal DE, Hunt RA, Kule CE, et al. Molecular mechanisms of angiotensin Ⅱ in modulating cardiac function: intracardiac effects and signal transduction pathways. J Mol Cell Cardiol, 1997, 29(11): 2893-2902.
11. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal, 1997, 9(5): 337-351.
12. Ushio-Fukai M, Alexander RW, Akers M, et al. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin Ⅱ. Role in vascular smooth muscle cell hypertrophy. J Biol Chem, 1998, 273(24): 15022-15029.
13. Zou Y, Komuro I, Yamazaki T, et al. Cell type-specific angiotensin Ⅱ-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts. Circ Res, 1998, 82(3): 337-345.
14. Adam O, Lavall D, Theobald K, et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol, 2010, 55(5): 469-480.
15. Abo A, Pick E, Hall A, et al. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature, 1991, 353(6345): 668-670.
16. Adam O, Frost G, Custodis F, et al. Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol, 2007, 50(4): 359-367.
17. Dudley SC Jr, Hoch NE, McCann LA, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation, 2005, 112(9): 1266-1273.
18. Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest, 2001, 108(10): 1429-1437.
19. Adam O, Neuberger HR, Böhm M, et al. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation, 2008, 118(12): 1285-1293.
20. McGaffin KR, Zou B, McTiernan CF, et al. Leptin attenuates cardiac apoptosis after chronic ischaemic injury. Cardiovasc Res, 2009, 83(2): 313-324.
21. Paradis P, Dali-Youcef N, Paradis FW, et al. Overexpression of angiotensin Ⅱ type Ⅰ receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A, 2000, 97(2): 931-936.
22. Yue H, Li W, Desnoyer R, et al. Role of nuclear unphosphorylated STAT3 in angiotensin Ⅱ type 1 receptor-induced cardiac hypertrophy. Cardiovasc Res, 2010, 85(1): 90-99.